Intel CEO's indirect investment in Lumilens (which holds warrants for 23M POET shares) signals potential future collaboration between Intel and POET, supported by Lumilens' $50M+ purchase order and top-2 hyperscaler customer. Key risks include speculative nature of Intel-Lumilens deal, POET's profitability timeline, and dependence on scaling the initial purchase order.

AAOI is a vertically integrated optical supplier positioned as a critical chokepoint in the AI networking supply chain, with actual demand ($1.4-1.5B) significantly exceeding guided capacity ($1.1B), suggesting substantial undervaluation despite a 600% run-up from $15 to $200. Key risks include the company's history of GAAP losses, extremely high beta (3.71) indicating volatility, execution risk on capacity expansion, and potential demand destruction if AI capex cycles slow.

POET Technologies raised $75M from an unnamed institutional investor, likely a major AI company needing optical interconnects for GPU data center networking. The company has real production orders, partnerships with Foxconn and Semtech, and critical technology for AI infrastructure scaling, but faces execution risk and the mystery investor's identity will be revealed in a 13D/13G filing by October 17th.